Depression and Anxiety Trial, Not Yet Recruiting NCT07406321 Sponsor: Ather Mujitaba Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Not Yet Recruiting

NCT07406321
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who are between 18 and 25 years old.
  • People who score above 19 on a questionnaire called the Social Phobia Inventory, which measures social anxiety.
  • People whose social anxiety is rated as at least moderately severe based on a standard assessment tool used by clinicians.
  • People who are able to read the study materials.
  • People who agree to participate and sign a written consent form.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People whose depression symptoms score above 16 on a questionnaire called the Beck Depression Inventory-II, which is considered a clinically elevated level.
  • People whose general anxiety symptoms score above 20 on a questionnaire called the Beck Anxiety Inventory, which is considered a clinically elevated level.
  • People who have a current medical or mental health condition that is likely to interfere with safe or valid participation in the trial.
  • People who have previously taken part in this trial.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 29 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Saima Riaz Riaz, PhD, University of Gujrat

Phone: +923297596056

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Ather Mujitaba
Registry
ClinicalTrials.gov
Start date
1 February 2026
Est. completion
1 April 2026

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇵🇰 Pakistan

Primary endpoints

short version of the Spielberger State-Trait Anxiety Inventory; Spielberger short-form State-Trait Anxiety Inventory (S-STAI)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 29 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov